Evaluation and Management of Mild Hyponatremia in Stable Hospitalized Patients

Mild hyponatremia, defined as a serum sodium concentration between 130 and 134 mmol/L, is a frequent finding among stable hospitalized patients. Despite being often overlooked, accumulating evidence links this condition to adverse outcomes, including impaired cognition, gait instability, prolonged hospitalization, and increased mortality. The subtle nature of symptoms contributes to underrecognition, especially in older adults, where the physiological impact may be more pronounced. Even small deviations from normal sodium levels can compromise clinical recovery and increase vulnerability to complications such as falls and fractures. Evaluation of mild hyponatremia remains inconsistent across clinical settings. Urine studies and fluid status assessments are frequently omitted or delayed, and treatment is often initiated without a clear understanding of the underlying cause. Guidelines exist but are not always integrated into routine hospital workflows, resulting in wide variations in practice. Volume status misclassification, inadequate monitoring, and lack of targeted diagnostic efforts continue to pose challenges. Limited education around the clinical implications of mild hyponatremia further contributes to therapeutic hesitation or inappropriate correction. Management strategies include fluid restriction, medication review, and in selected cases, pharmacologic intervention using vasopressin receptor antagonists or hypertonic saline. However, concerns about overcorrection, treatment risks, and access barriers often lead to conservative approaches that may not address the root cause. Despite these challenges, correction of mild hyponatremia has been associated with improved physical function and reduced hospital readmissions. Enhancing clinician awareness, standardizing evaluation protocols, and addressing system-level barriers are necessary steps to improve the management and outcomes of this often-underestimated condition.